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The Morbidity of Secondary Vascular Access. A Lifetime of Intervention
A. C. Ruddle, P. A. Lear and D. C. Mitchell
Department of Vascular Surgery, Southmead Hospital, Bristol BS10 5NB, U.K.
Objectives: to examine the outcome and incidence of access-related procedures in patients who dialyse via PTFE secondary
access grafts.
Design: retrospective case note study.
Results: recipients of secondary access procedures face a lifetime of haemodialysis access interventions. In total, 639
access-related procedures were performed on the 72 patients studied. At the end of the study five patients were wholly
reliant on central venous catheters for dialysis access.
Patients with secondary access grafts have little hope of transplantation; only six of 72 patients received a transplant
after a secondary access procedure.
Conclusion: the increasing number of patients coming to synthetic access-graft procedures and the morbidity of such
procedures mean that surgeons should adopt strategies to minimise the use of grafts and limit the number of interventions
performed. Careful planning will also reduce the number of central line placements and help to reduce the morbidity
associated with long-term haemodialysis. Increasing resources will be required to meet the rising demand for secondary
access provision.
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Introduction performed on patients who ultimately require syn-
thetic access-graft placement. We also examined over-
Increasing acceptance of elderly patients onto dialysis all patient outcome in this difficult group of patients.
programmes and improved dialysis therapy has res-
ulted in more patients receiving treatment for end-
stage renal failure (ESRF). World-wide the incidence
Patients and Methodof treated ESRF is expected to double in the last decade
of this century.1 The continuing shortage of organs We conducted a retrospective case note study of allfor renal transplantation means that many patients patients who received a polytetrafluoroethyleneaccepted for ESRF treatment face life-long haemo- (PTFE, Impra) haemodialysis graft, placed betweendialysis. Autologous fistula is the optimal method of July 1991 and July 1996. Graft placements were iden-
haemodialysis access.2 In patients who do not have tified through the renal unit computerised database
suitable veins, or to avoid the need to await fistula and operation records.
maturation, haemodialysis access may require the use Patients underwent access-grafting following failure
of synthetic grafts (secondary access), or central lines. of native arteriovenous fistula (AVF) or failure of such
The results of secondary access procedures vary, prob- fistula to mature. It was our policy to exhaust forearm
ably due to the indications for placement and how and antecubital fossa veins prior to placement of access
aggressively graft malfunction is treated. grafts. Thigh grafts were used when arm veins were
We examined the morbidity associated with failure absent or arm-swelling prevented their use. Arm-
to establish a native arteriovenous fistula. Our study swelling was seen in some patients who had under-
focused on the number of access-related procedures gone numerous subclavian-line placements and was
presumed to be secondary to central venous stenosis.
Duplex scanning and venography were not routinely
used during the period under study. All graft place-
* Please address all correspondence to: D. C. Mitchell, Department of ments received prophylactic antibiotics and were notVascular Surgery, Southmead Hospital, Westbury-on-Trym, Bristol
BS10 5NB, U.K. used until at least 10 days had elapsed.
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Table 1. Cumulative graft survival.
Graft type Mean Number
survival of graftPatency rates were analysed by the Kaplan–Meier
(months) interventions
life-table methods. Log rank tests were used to com-
All grafts n=104 20.4 s.e. 2.2 54pare groups. Graft failure was defined as graft oc-
Upper arm n=45 17.1 s.e. 2.1 18clusion, or graft removal/part removal for sepsis,
Forearm straight n=21 25.4 s.e. 5.8 11
whether requiring graft revision or replacement by a Forearm loop n=21 11.3 s.e. 1.8 14
Thigh n=17 13.1 s.e. 4.9 11new site of access.
Table 2. Interventions for graft mal-Results
function.
In total there were 104 grafts placed in 72 patients in Complication Number of
interventionsthe five-year period studied (43 male and 29 female,
mean age 52 years, range 19–76 years, including 14
Occlusion 22
diabetic patients with 19 grafts). Sepsis 21
Aneurysm 7Grafts were placed in the forearm, wherever a suit-
Haemorrhage 4able artery and vein could be identified. There were
Steal 1
21 straight forearm grafts from radial artery to a vein
in the antecubital fossa. A further 21 grafts were placed
in a forearm loop configuration between brachial artery
and an antecubital vein. The majority of grafts (n= months (Table 1). There was no significant difference in
45) were placed in an upper arm straight configuration secondary patency rates between graft configurations
between the brachial artery in the antecubital fossa (log rank test).
and the basilic or brachial vein at the level of the
axillary floor. Seventeen femoral artery to long
saphenous vein thigh-loop grafts were also placed
(Fig. 1).
Graft malfunction
During the study period there were 51 grafts that
required intervention for malfunction as shown inGraft survival complications and interventions
Table 2. The commonest cause of graft failure was
thrombosis caused by outflow vessel stenosis or throm-The overall one-year secondary patency across all graft
types was 56% (Fig. 2). Mean graft patency was 20.4 bosis during low flow states associated with post-
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Table 3. Overall patient outcome at the end of the study
period.
Patient outcome Number of
patients
Functioning access graft 48
Functioning transplant 6
Patient death 11
Dialysis via central line 5
Dialysis via fistula 2
Table 4. Total procedures to maintain haemodialysis access.
Procedure Count
Central line insertion 310
Fistula formation 122Technical
25
0
Graft
occlusion
20
15
10
5
Graft
sepsis
Aneurysm Steal
Fistula revision 33
PTFE graft placement 104Fig. 3. Causes of graft failure. PTFE intervention 53
Other secondary access grafts 7
dialysis hypotension. Graft sepsis was the second com-
monest cause of graft failure (21% of grafts) (Fig. 3).
In total, there were 54 interventions for graft mal-
function. Fourteen patients required a total of 22 two with functioning access grafts. Two patients were
interventions for graft occlusion. Simple graft throm- dialysing through an autologous fistula. Five patients
bectomy was performed in 12 cases, thrombolysis were wholly dependent on central venous catheters
in one, and in nine cases graft thrombectomy was (Table 3).
combined with a procedure to treat outflow ob- These 72 patients who underwent synthetic access
struction (thrombectomy plus skip graft n=7, throm- grafting had been treated for a total of 383 years, since
bectomy plus angioplasty n=2). onset of haemodialysis. In this time a total of 639
Graft occlusions treated by thrombectomy or lysis procedures were performed to maintain haemodialysis
alone all rapidly re-occluded (time to re-occlusion access (Table 4).
median 18 days, interquartile range (IQR) 39, n=13).
Where thrombectomy was combined with an outflow
procedure there was a trend to better long-term pat-
ency, with the median time to re-occlusion being 210
Transplant historydays (IQR 112, n=4). Five grafts were still patent at
the end of the study period after a median follow-up
Of the 72 patients in this study, 25 patients had receivedof 317 days (IQR 208, n=5).
a total of 34 renal transplants at some time duringFourteen patients underwent 21 operative pro-
their treatment for renal failure. In the patients studied,cedures for graft sepsis, in one case complicated by
18 had received one transplant, five had been trans-haemorrhage. In 17 cases the grafts were excised and
planted twice and two patients had been transplanteda new graft sited elsewhere. On four occasions grafts
three times.were successfully treated by local debridement com-
Only six patients received a renal transplant fol-bined with excision and replacement of infected sec-
lowing a secondary access procedure.tions of graft. Thigh grafts had the highest rate of
interventions for graft sepsis. The commonest infecting
organisms were Staphylococci and Coliform sp.
All patients in whom grafts required re-exploration,
Incidence of secondary access proceduresfor thrombosis or re-siting, were anticoagulated.
During the study period there was an increase in the
number of patients treated by haemodialysis by ourPatient outcome
unit. This has been caused by an increase in demand
for dialysis. The number of secondary access place-At the end of the study period, 48 patients were still
dialysing via an access graft. Eleven patients had died, ments has risen rapidly during this period. The number
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rection of outflow tract abnormality is essential if
revision procedures are to be successful. It has been
proposed that it is more effective to replace rather
than revise thrombosed access grafts.7 During the
period under study five of our patients had exhausted
all potential sites for definitive access procedures and
were wholly reliant on central venous catheters. Patient
access opportunities are finite and all attempts should
be made to prolong the use of an access site before
using a new graft site.
Graft sepsis accounted for 21% of graft failures. In
particular, thigh grafts had a high incidence of graft
sepsis. Attempts to lessen graft sepsis may contribute
to improving the results of secondary access pro-Jul 95–Jul 96
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cedures. Avoidance of thigh grafts may reduce sepsis
Fig. 4. Number of PTFE access-graft placements, renal transplants
rates, but such grafts may be required if arm veins areand patients on haemodialysis per annum. (F) Number of patients
receiving haemodialysis; (Ú) number of PTFE graft implantations; exhausted or blocked. Vein allografts have dem-
(E) transplants. onstrated resistance to infection in both haemodialysis8
and peripheral vascular surgery. In patients and graft
sites susceptible to infection, vein allografts may offer
of patients treated by haemodialysis with the number an alternative to PTFE grafts. This area merits further
of PTFE access grafts and transplants is shown in Fig. research.
4.
Conclusions
Discussion
The increasing number of patients coming to synthetic
The rise in the haemodialysis population is not being access-grafts procedures and the morbidity of such
accompanied by a commensurate rise in the number procedures mean that surgeons should adopt strat-
of transplants. We have seen that secondary access egies to minimise the use of grafts. Careful planning
recipients are a selected population with a low prob- will also reduce the number of central line placements
ability of obtaining a functioning renal transplant. and help to reduce the morbidity associated with long-
Despite a policy of aggressive use of native vessel term haemodialysis.
arteriovenous fistula, our unit is seeing a relentless
rise in the need for synthetic access grafts.
Secondary access-graft recipients have a high access-
related morbidity with numerous interventions re- Acknowledgements
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